4.7 Review

Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

GD2-CART cell therapy for H3K27M-mutated diffuse midline gliomas

Robbie G. Majzner et al.

Summary: Diffuse intrinsic pontine glioma (DIPG) and other H3K27M-mutated diffuse midline gliomas (DMGs) are lethal pediatric tumors of the central nervous system. GD2-directed chimeric antigen receptor (CAR) T cells show promising preclinical efficacy. Four patients with H3K27M-mutated DIPG or spinal cord DMG were treated with GD2-CAR T cells and showed clinical and radiographic improvement.

NATURE (2022)

Article Oncology

Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine

Melanie Pages et al.

Summary: The study systematically evaluated the feasibility of profiling pediatric brain tumors using ctDNA obtained from plasma, CSF, and urine. Results showed that most samples had very low levels of somatic mutations, posing a challenge for detection using whole-genome or targeted sequencing methods. Substantial challenges remain in genetically characterizing pediatric brain tumors from liquid biopsies.

NEURO-ONCOLOGY (2022)

Article Oncology

Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report

Jack M. Su et al.

Summary: The phase I/II trial of vorinostat in children with newly diagnosed DIPG showed that the regimen of vorinostat given concurrently with radiation followed by vorinostat monotherapy was well tolerated but did not significantly improve outcomes.

NEURO-ONCOLOGY (2022)

Article Oncology

Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial

Jason Fangusaro et al.

Summary: Pomalidomide shows tolerance and immune modulation in pediatric CNS tumors, making it a potential treatment option. The maximum tolerated dose for this drug was determined to be 2.6 mg/m(2), with attention needed for adverse events like myelosuppression.

PEDIATRIC BLOOD & CANCER (2021)

Article Pathology

Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity

Kathryn L. Eschbacher et al.

Summary: Research shows that adult patients with posterior fossa diffuse gliomas exhibit molecular heterogeneity, which may impact patient outcomes and treatment responses. The tumors can be classified into four distinct genetic groups, with most cases showing mutations in the driver genes. Patients with TERT promoter mutations have a shorter survival time compared to other subgroups.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Review Clinical Neurology

Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs

Julian S. Rechberger et al.

CHILDS NERVOUS SYSTEM (2020)

Article Clinical Neurology

Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma

Ai Muroi et al.

CHILDS NERVOUS SYSTEM (2020)

Review Oncology

CAR T Cell Therapy for Pediatric Brain Tumors

John D. Patterson et al.

FRONTIERS IN ONCOLOGY (2020)

Review Cell Biology

Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential

Alexandre Perla et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Histone H3.3G34-Mutant Intemeuron Progenitors Co-opt PDGFRA for Gliomagenesis

Carol C. L. Chen et al.

Article Multidisciplinary Sciences

ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis

Christine M. Hoeman et al.

NATURE COMMUNICATIONS (2019)

Article Oncology

Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas

John P. Welby et al.

FRONTIERS IN ONCOLOGY (2019)

Review Biochemical Research Methods

Signal Transduction in Diffuse Intrinsic Pontine Glioma

Ryan J. Duchatel et al.

PROTEOMICS (2019)

Article Oncology

TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG)

Coralie Werbrouck et al.

CLINICAL CANCER RESEARCH (2019)

Article Oncology

Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

Fatma E. El-Khouly et al.

JOURNAL OF NEURO-ONCOLOGY (2019)

Editorial Material Oncology

Reirradiation in Pediatric Patients With Recurrent Brain Tumors: A Last Hope, But One With Greatly Feared Consequences

Ralph Ermoian et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Article Endocrinology & Metabolism

Variable signaling activity by FOP ACVR1 mutations

Julia Haupt et al.

Article Biochemistry & Molecular Biology

Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas

Christopher W. Mount et al.

NATURE MEDICINE (2018)

Article Multidisciplinary Sciences

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

Mariella G. Filbin et al.

SCIENCE (2018)

Review Biochemistry & Molecular Biology

Targeting oncogenic Myc as a strategy for cancer treatment

Hui Chen et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)

Review Biochemistry & Molecular Biology

Signaling pathways and mesenchymal transition in pediatric high-grade glioma

Michael H. Meel et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Review Neurosciences

Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment

Zhiping Zhou et al.

CURRENT NEUROPHARMACOLOGY (2017)

Review Oncology

Wnt/beta-catenin pathway: modulating anticancer immune response

Sachin Gopalkrishna Pai et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)

Article Biochemistry & Molecular Biology

EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas

Faizaan Mohammad et al.

NATURE MEDICINE (2017)

Article Biochemistry & Molecular Biology

Combination of EZH2 inhibitor and BET inhibitor for treatment of diffuse intrinsic pontine glioma

Yaqin Zhang et al.

CELL AND BIOSCIENCE (2017)

Review Pharmacology & Pharmacy

Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma

Wenyong Long et al.

FRONTIERS IN PHARMACOLOGY (2017)

Review Genetics & Heredity

Modeling and Targeting MYC Genes in Childhood Brain Tumors

Sonja Hutter et al.

Article Clinical Neurology

Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism

Tammy Hennika et al.

JOURNAL OF CHILD NEUROLOGY (2016)

Review Oncology

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy

Catherine Alix-Panabieres et al.

CANCER DISCOVERY (2016)

Article Medicine, Research & Experimental

Tumor-Suppressor Functions of the TP53 Pathway

Brandon J. Aubrey et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)

Review Oncology

H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer

J. N. Nichol et al.

ADVANCES IN CANCER RESEARCH, VOL 131 (2016)

Article Multidisciplinary Sciences

Chromothripsis from DNA damage in micronuclei

Cheng-Zhong Zhang et al.

NATURE (2015)

Correction Biochemistry & Molecular Biology

Functionally defined therapeutic targets in diffuse intrinsic pontine glioma (vol 21, pg 555, 2015)

Catherine S. Grasso et al.

NATURE MEDICINE (2015)

Review Biotechnology & Applied Microbiology

Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment

Daniela Rizzo et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Review Oncology

Targeting the Hedgehog Pathway in Pediatric Medulloblastoma

Sherri Y. Huang et al.

CANCERS (2015)

Review Oncology

Pathology, molecular genetics, and epigenetics of diffuse intrinsic pontine glioma

Pawel Buczkowicz et al.

FRONTIERS IN ONCOLOGY (2015)

Review Oncology

DIPG in children - what can we learn from the past?

Magimairajan Issai Vanan et al.

FRONTIERS IN ONCOLOGY (2015)

Review Oncology

A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands

Sophie E. M. Veldhuijzen van Zanten et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2015)

Editorial Material Clinical Neurology

Subventricular spread of diffuse intrinsic pontine glioma

Viola Caretti et al.

ACTA NEUROPATHOLOGICA (2014)

Review Oncology

ACVR1 Mutations in DIPG: Lessons Learned from FOP

Kathryn R. Taylor et al.

CANCER RESEARCH (2014)

Article Biochemistry & Molecular Biology

Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma

Rintaro Hashizume et al.

NATURE MEDICINE (2014)

Review Oncology

Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge

Dominik Sturm et al.

NATURE REVIEWS CANCER (2014)

Editorial Material Cell Biology

Poisoning the histone code in pediatric gliomagenesis

Peter W. Lewis et al.

CELL CYCLE (2013)

Article Oncology

Hypofractionation vs Conventional Radiation Therapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Matched-Cohort Analysis

Geert O. Janssens et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)

Review Oncology

HDAC inhibitor-based therapies: Can we interpret the code?

Maria New et al.

MOLECULAR ONCOLOGY (2012)

Article Oncology

Post mortem examinations in diffuse intrinsic pontine glioma: challenges and chances

Paola Angelini et al.

JOURNAL OF NEURO-ONCOLOGY (2011)

Article Multidisciplinary Sciences

Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma

Michelle Monje et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Pediatrics

Neurological complications following treatment of children with brain tumors

Michelle Monje et al.

JOURNAL OF PEDIATRIC REHABILITATION MEDICINE (2011)

Article Biochemistry & Molecular Biology

Histone H3 Exerts a Key Function in Mitotic Checkpoint Control

Jianjun Luo et al.

MOLECULAR AND CELLULAR BIOLOGY (2010)

Review Clinical Neurology

Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies

James L. Frazier et al.

JOURNAL OF NEUROSURGERY-PEDIATRICS (2009)

Article Clinical Neurology

Image-guided convection-enhanced delivery platform in the treatment of neurological diseases

Massimo S. Fiandaca et al.

NEUROTHERAPEUTICS (2008)

Review Oncology

Advances toward an understanding of brainstem gliomas

SS Donaldson et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

Article Clinical Neurology

Clinicopathological study of diffuse type brainstem gliomas: Analysis of 40 autopsy cases

J Yoshimura et al.

NEUROLOGIA MEDICO-CHIRURGICA (2003)

Review Biochemistry & Molecular Biology

Cell signaling by receptor tyrosine kinases

J Schlessinger